BMJ 1995;310:353-357 (11 February)

Papers

Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening

Zosia H Miedzybrodzka, Wellcome research fellow,a Marion H Hall, consultant obstetrician,b Jill Mollison, research assistant,c Allan Templeton, regius professor,b Ian T Russell, formerly director,c John C S Dean, consultant geneticist,a Kevin F Kelly, principal molecular geneticist,a Theresa M Marteau, director,d Neva E Haites, senior lecturer a

a University of Aberdeen, Medical Genetics, Polwarth Building, Foresterhill, Aberdeen AB9 2ZD, b Department of Obstetrics and Gynaecology, Aberdeen Maternity Hospital, Foresterhill, Aberdeen AB9 2ZD, c Health Services Research Unit, Drew Kay Wing, Polwarth Building, Foresterhill, Aberdeen AB9 2ZD, d Psychology and Genetics Research Group, United Medical and Dental Schools of Guy's and St Thomas's Hospitals, Guy's Campus, London SE1 9RT

Correspondence to: Dr Miedzybrodzka.

Abstract

Objective: To perform a rigorous comparative evaluation of stepwise and couple approaches to antenatal carrier screening for cystic fibrosis.
Design: Pragmatic randomised trial.
Setting: Hospital antenatal clinic serving a regional population.
Subjects: 2002 women (couples) attending for booking antenatal visit at less than 17 weeks' gestation with no family history of cystic fibrosis.
Interventions: Offering counselling and carrier testing for cystic fibrosis, either to women in the first instance (stepwise) or to couples (couple screening).
Main outcome measures: Uptake rates; anxiety; knowledge of cystic fibrosis and carrier status (both partners); attitudes to health, pregnancy, the baby, and screening (both partners); and uptake of carrier testing by relatives.
Results: Uptake of screening was the same for both approaches (90%). After delivery most women remembered test results and their meaning, but 53/253 (21%) of those with negative results of couple testing had forgotten that repeat testing would be advisable if they had a pregnancy with a new partner. With stepwise screening women identified as carriers had high levels of anxiety when results were received (mean anxiety score 52.3). This dissipated with a reassuring partner's result (carriers' mean anxiety score 36.1) to levels similar to those receiving negative results from couple screening. Of those receiving negative results, women who had stepwise screening were significantly less anxious than those who had couple screening (mean score with result 32.1 v 35.4, 95% confidence interval for difference -4.7 to -2.1).
Conclusions: Couple screening allows carriers to avoid transient high levels of anxiety, but is associated with more anxiety and false reassurance among most screenees who will test negative. Stepwise screening gives carriers and their relatives genetic information and is, in our opinion, the better method.

Key messages

  • Key messages

  • This study compares the stepwise and couple approaches to antenatal screening for carriers of cystic fibrosis

  • With stepwise screening carriers experience transiently high levels of anxiety that dissipate when the partner's negative result becomes available

  • Carriers identified by stepwise screening inform most of their siblings about their genetic risk

  • Couple screening is associated with more anxiety and more false reassurance among most screenees, who will have negative results

  • On balance, the authors judge stepwise screening to be the better method


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Antenatal screening for cystic fibrosis
Nicholas J Wald, David J H Brock, James E Haddow, and Richard A Doherty
BMJ 1995 310: 1199. [Extract] [Full Text]

This article has been cited by other articles:

  • Gardner, F, Dezateux, C, Elbourne, D, Gray, A, King, A, Quinn, A, on behalf of the Collaborative Hip Trial Group, (2005). The hip trial: psychosocial consequences for mothers of using ultrasound to manage infants with developmental hip dysplasia. Arch. Dis. Child. Fetal Neonatal Ed. 90: F17-F24 [Abstract] [Full text]  
  • Henneman, L, ten Kate, L P (2002). Preconceptional couple screening for cystic fibrosis carrier status: couples prefer full disclosure of test results. J. Med. Genet. 39: e26-26 [Full text]  
  • Henneman, L, Bramsen, I, van der Ploeg, H M, Ader, H J, van der Horst, H E, Gille, J J P, ten Kate, L P (2001). Participation in preconceptional carrier couple screening: characteristics, attitudes, and knowledge of both partners. J. Med. Genet. 38: 695-703 [Full text]  
  • Graham, W., Smith, P., Kamal, A, Fitzmaurice, A, Smith, N, Hamilton, N, Wyatt, J. (2000). Randomised controlled trial comparing effectiveness of touch screen system with leaflet for providing women with information on prenatal tests • Commentary: Evaluating electronic consumer health material. BMJ 320: 155-160 [Abstract] [Full text]  
  • Emery, J., Watson, E., Rose, P., Andermann, A. (1999). A systematic review of the literature exploring the role of primary care in genetic services. Fam Pract 16: 426-445 [Abstract] [Full text]  
  • Bogardus, S. T. Jr, Concato, J., Feinstein, A. R. (1999). Clinical Epidemiological Quality in Molecular Genetic Research: The Need for Methodological Standards. JAMA 281: 1919-1926 [Abstract] [Full text]  
  • Kronn, D., Jansen, V., Ostrer, H. (1998). Carrier Screening for Cystic Fibrosis, Gaucher Disease, and Tay-Sachs Disease in the Ashkenazi Jewish Population: The First 1000 Cases at New York University Medical Center, New York, NY. Arch Intern Med 158: 777-781 [Abstract] [Full text]  
  • De Braekeleer, M. (1996). Prenatal screening for carriers of cystic fibrosis should screen both partners individually. BMJ 313: 820b-821 [Full text]  
  • Cairns, J., Shackley, P., Hundley, V. (1996). Decision Making with Respect to Diagnostic Testing: A Method of Valuing the Benefits of Antenatal Screening. Med Decis Making 16: 161-168 [Abstract]  
  • Cuckle, H S, Richardson, G A, Sheldon, T A, Quirke, P (1995). Cost effectiveness of antenatal screening for cystic fibrosis. BMJ 311: 1460-1460 [Abstract] [Full text]  
  • Wald, N. J, Brock, D. J H, Haddow, J. E, Doherty, R. A (1995). Antenatal screening for cystic fibrosis. BMJ 310: 1199a-1199 [Full text]  
Access jobs at BMJ Careers
Whats new online at Student BMJ